Trial Profile

Phase 2 study of TTP399 in patients with Type 2 diabetes on insulin therapy

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 11 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cadisegliatin (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors vTv Therapeutics LLC

Most Recent Events

04 Mar 2024 According to a vTv Therapeutics LLC media release, the company expects to start this trial in Middle Eastern countries in 2024
10 Mar 2023 New trial record
06 Mar 2023 According to a vTv Therapeutics LLC media release, the company expect to initiate this trial in collaboration with an affiliate of G42 Investments in 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com